Is provenge (sipuleucel-t) the leading treatment of prostate cancer?

It's only for some: Provenge (sipuleucel-t) is used in a very specific clinical situation with prostate cancer--definitely not indicated for everyone. The best treatment depends on the stage and grade of the cancer.

NO: Provenge( sipuleucel t ) is the first autologous cellular immuno therapeutic vaccine it is prepared from the same patient, just for that patient only. Indication are for castrate resistant ( hormone )cancers that did not spread too much, so use is limited, besides being expensive, and current data is too small.. So leading treatments are still the proven traditional treatments

No: Very few people get to this level of treatment, usually late stage therapy.

A standard option: Provenge (sipuleucel-t) is a standard option for men who have progressive disease despite hormonal therapy and no or minimal symptoms. It probably is most effective earlier in the disease course before the tumors are too large. There have been two randomized phase iii trials proving efficacy.